The company reported great fiscal 2021 Q2 results.
News & Analysis: Avid Bioservices, Inc.
CDMO earnings call for the period ending October 31, 2020.
CDMO earnings call for the period ending July 31, 2020.
The company still had significant production problems. But it also picked up a lot of new business in Q4.
CDMO earnings call for the period ending April 30, 2020.
These two businesses offer compelling growth potential, but one has yet to deliver on its promise and the other just became more complicated thanks to the coronavirus pandemic.
The drug manufacturer encountered an operational setback, which forced it to slash revenue guidance.
CDMO earnings call for the period ending January 31, 2020.
These two small-cap stocks are risky, but not as risky as penny stocks. And buying a small stake in either company could actually pay off for patient investors.
The drug manufacturing company reported operating results for its fiscal second quarter.